Literature DB >> 20123724

Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity.

Shannon Levesque1, Belinda Wilson, Vincent Gregoria, Laura B Thorpe, Shannon Dallas, Vadim S Polikov, Jau-Shyong Hong, Michelle L Block.   

Abstract

Microglia, the innate immune cells in the brain, can become chronically activated in response to dopaminergic neuron death, fuelling a self-renewing cycle of microglial activation followed by further neuron damage (reactive microgliosis), which is implicated in the progressive nature of Parkinson's disease. Here, we use an in vitro approach to separate neuron injury factors from the cellular actors of reactive microgliosis and discover molecular signals responsible for chronic and toxic microglial activation. Upon injury with the dopaminergic neurotoxin 1-methyl-4-phenylpyridinium, N27 cells (dopaminergic neuron cell line) released soluble neuron injury factors that activated microglia and were selectively toxic to dopaminergic neurons in mixed mesencephalic neuron-glia cultures through nicotinamide adenine dinucleotide phosphate oxidase. mu-Calpain was identified as a key signal released from damaged neurons, causing selective dopaminergic neuron death through activation of microglial nicotinamide adenine dinucleotide phosphate oxidase and superoxide production. These findings suggest that dopaminergic neurons may be inherently susceptible to the pro-inflammatory effects of neuron damage, i.e. reactive microgliosis, providing much needed insight into the chronic nature of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123724      PMCID: PMC2860703          DOI: 10.1093/brain/awp333

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  52 in total

1.  Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase.

Authors:  Sang-Ho Choi; Da Yong Lee; Seung Up Kim; Byung Kwan Jin
Journal:  J Neurosci       Date:  2005-04-20       Impact factor: 6.167

Review 2.  Regulating cell migration: calpains make the cut.

Authors:  Santos J Franco; Anna Huttenlocher
Journal:  J Cell Sci       Date:  2005-09-01       Impact factor: 5.285

Review 3.  Calpains and disease.

Authors:  Mayana Zatz; Alessandra Starling
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

Review 4.  Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.

Authors:  Michelle L Block; Jau-Shyong Hong
Journal:  Prog Neurobiol       Date:  2005-06       Impact factor: 11.685

5.  Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo.

Authors:  Sang H Choi; Da Y Lee; Eun S Chung; Young B Hong; Seung U Kim; Byung K Jin
Journal:  J Neurochem       Date:  2005-10-07       Impact factor: 5.372

6.  Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis.

Authors:  M Kelly Guyton; J Michael Wingrave; Anil V Yallapragada; Gloria G Wilford; Eric A Sribnick; Denise D Matzelle; William R Tyor; Swapan K Ray; Naren L Banik
Journal:  J Neurosci Res       Date:  2005-07-01       Impact factor: 4.164

Review 7.  Calpain: a death protein that mediates progression of liver injury.

Authors:  Harihara M Mehendale; Pallavi B Limaye
Journal:  Trends Pharmacol Sci       Date:  2005-05       Impact factor: 14.819

8.  Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat.

Authors:  Robert Siman; Chen Zhang; Victoria L Roberts; Alex Pitts-Kiefer; Robert W Neumar
Journal:  J Cereb Blood Flow Metab       Date:  2005-11       Impact factor: 6.200

9.  Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.

Authors:  J W Langston; L S Forno; J Tetrud; A G Reeves; J A Kaplan; D Karluk
Journal:  Ann Neurol       Date:  1999-10       Impact factor: 10.422

10.  Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion.

Authors:  Lijun Xu; Xingming Deng
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

View more
  48 in total

Review 1.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

2.  Translocator protein 18 kDa negatively regulates inflammation in microglia.

Authors:  Keun-Ryung Bae; Hyun-Jung Shim; Deebika Balu; Sang Ryong Kim; Seong-Woon Yu
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-01       Impact factor: 4.147

3.  The expression and release of Hsp60 in 6-OHDA induced in vivo and in vitro models of Parkinson's disease.

Authors:  Mei jiang Feng; Ling Zhang; Zhengxia Liu; Ping Zhou; Xiang Lu
Journal:  Neurochem Res       Date:  2013-08-14       Impact factor: 3.996

Review 4.  Microglial priming in Alzheimer's disease.

Authors:  Jun-Wei Li; Yu Zong; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

5.  Redox regulation of NF-κB p50 and M1 polarization in microglia.

Authors:  Thomas Taetzsch; Shannon Levesque; Constance McGraw; Savannah Brookins; Rafy Luqa; Marcelo G Bonini; Ronald P Mason; Unsong Oh; Michelle L Block
Journal:  Glia       Date:  2014-10-21       Impact factor: 7.452

6.  Dexmedetomidine Regulates 6-hydroxydopamine-Induced Microglial Polarization.

Authors:  Pei Zhang; Yu Li; Xuechang Han; Qunzhi Xing; Lei Zhao
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

7.  Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.

Authors:  Monica R Langley; Shivani Ghaisas; Muhammet Ay; Jie Luo; Bharathi N Palanisamy; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2017-06-20       Impact factor: 4.294

Review 8.  Outdoor Ambient Air Pollution and Neurodegenerative Diseases: the Neuroinflammation Hypothesis.

Authors:  Richard L Jayaraj; Eric A Rodriguez; Yi Wang; Michelle L Block
Journal:  Curr Environ Health Rep       Date:  2017-06

9.  Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases.

Authors:  Qingshan Wang; Chun-Hsien Chu; Esteban Oyarzabal; Lulu Jiang; Shih-Heng Chen; Belinda Wilson; Li Qian; Jau-Shyong Hong
Journal:  Glia       Date:  2014-07-17       Impact factor: 7.452

10.  Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model.

Authors:  Tanya Chotibut; Richard W Davis; Jennifer C Arnold; Zachary Frenchek; Shawn Gurwara; Vimala Bondada; James W Geddes; Michael F Salvatore
Journal:  Mol Neurobiol       Date:  2013-12-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.